Delivery Order SPE2DB22D2206-SPE2DB24FJN96

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Amerisourcebergen Corporation) for the delivery of 4564405113 - Deferiprone 500 mg Tablets in 100-count packages. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, and has a firm fixed-price value of $7,744.88. The award does not indicate the use of a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,381.78 firm fixed-price delivery order is for the supply of 4567164537 DEFERIPRONE 500 MG TABLET 100S. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, with a ceiling value of $34,899.12, is for the provision of Deferiprone 500 mg tablets to support military treatment programs and facilities. The contract is a firm fixed price delivery order with an ultimate completion date of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,338.05, is for the delivery of the pharmaceutical drug Deferasirox 180 mg Tablet 30s. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 30, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $86,425.17 Firm Fixed Price Delivery Order contract is for the supply of 4567057652 - DEFERASIROX 360 MG TABLET 30S, with a performance period ending on January 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $5,278.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award, valued at $1,045.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pirfenidone 267 mg tablets in quantities of 90s. This contract is not designated as a set-aside award. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical for $999,999,999,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DEFERASIROX 360 MG TABLET 30S. The firm fixed price contract has a potential value of $13,105.98 and a performance completion date of December 29, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) through a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999. The contract, which runs through November 2026, covers the delivery of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides delivery orders for Pirfenidone 267 mg tablets. The contract has a ceiling value of $4,272.21 and an ultimate completion date of October 18, 2024. It was awarded on October 17, 2024 by the Defense Logistics Agency (DLA), a defense agency, as a firm fixed-price delivery order contract. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJN96
    Delivery Order

This federal contract award is for the delivery of 50 tablets of the pharmaceutical drug deferiprone, 1,000 mg per tablet, with a 3-times-per-day dosage requirement. The contract, valued at $13,040.76, was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is a delivery order under the DLA's Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and has an ultimate completion date of August 2, 2024.

Generated 10/31/24, 9:07 AM